Oppenheimer & Co’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Oppenheimer & Co’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-33,000	Closed	-$415K	–	1529
2013 Q3	$415K	Buy	+33,000	New	+$437K	0.01%	832

Oppenheimer & Co's OPTR Position: Q4 2013 in Review

Oppenheimer & Co sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 33,000 shares — an estimated $415K sold.

Oppenheimer & Co first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $415K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

Oppenheimer & Co reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
Oppenheimer & Co sold 33,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $415K.
Oppenheimer & Co first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
Oppenheimer & Co's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $415K in Q3 2013.
0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.